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1. Introduction 
Endotoxemia causes mitochondrial alterations that 
have been characterized by both morphologic and 
enzymatic changes [l-9]. Endotoxin elicits a clear 
diminuition in respiratory control (RCR and ADP/O 
ratio) and succinate-cytochrome c reductase activity 
of liver mitochondria from shocked rats [lo], in 
agreement with the correlation between shock onset 
and loss of mitochondrial ability to maintain mem- 
brane-bound Mg2+ [5-91. Effectively, an intact 
mitochondrial membrane is required for oxidative 
phosphorylation and active cation transport [ 11 ,121 
and this integrity depends largely upon phospholipids 
[131. 
The content in arachidonic acid is highly diminished 
in both phosphatidylcholine and phosphatidylethanol- 
amine from shocked mitochondria; the released 
arachidonic acid contributes to the pool of mitochon- 
drial free fatty acids [lo]. 
To study further the molecular mechanisms of 
endotoxic shock, we have investigated the relation 
between the main mitochondrial phospholipids, and 
free fatty acids and calcium translocation in mito- 
chondria. 
2. Experimental 
Male Wistar rats (200-250 g body wt) were used 
in all experiments. They were fasted overnight and 
allowed water until the experiments were begun. 
Endotoxin shock was induced in unanesthetized 
rats by an intravenous (i.v.) injection of Escherichia 
coli lipopolysaccharide W (Difco Labs.) at 5 mg/kg 
body wt in 5 mg/ml saline solution. Shocked rats 
were classified in groups exhibiting either a reversible 
state of shock (E,) or an irreversible state with circu- 
latory collapse (E,) [ 141. Livers were quickly excised 
from the rats from which tissue homogenates or 
mitochondrial preparations were obtained [ 151. 
In the in vitro experiments 25 &i/animal of [2-14C]- 
ethanolamine hydrochloride (spec. act. 44 mCi/mmol; 
Amersham) was i.v. administered 1 h before sacrifice. 
Total lipids [ 161 were fractionated into lipid classes 
by thin-layer chromatography as in [ 171. Phospholipid 
classes were evaluated according to [ 181. Fatty acid 
methyl esters [ 191 were quantitated by the internal 
patron method [20]. Positional fatty acid distribution 
in phosphoglycerides was done as in [21]. 
Phospholipase A2 activity in mitochondria was 
measured as in [22] using 75 mM sucrose, 225 mM 
manitol, 20 mM Tris @H 7.4), 2 mM CaC12, 0.06 mg 
lipopolysaccharide/mg mitochondrial protein in 0.5 ml 
mitochondrial suspension (30 mg protein/ml) at 18°C 
for 30 min. Incubation was stopped with chloroform- 
methanol (2: 1 ,v/v). 
Calcium concentration in mitochondrial prepara- 
tions was determined through the absorbance changes 
at 540-5 10 nm in a dual wavelength Aminco DW-2a 
spectrophotometer using murexide as indicator, 
according to [23]. The assay medium was that described 
for the phospholipase A2 assay. 
Radioactivity measurements were carried out in a 
Packard 3255 liquid scintillation spectrometer using 
as scintillation mixture PPO 4 g, POPOP 100 mg and 
toluene to 1 liter. 
All biochemical reagents were from Sigma Chemical 
Co. (St Louis MO). Solvents were of analytical grade. 
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Table 1 
Percentages of lysophosphatidylethanolamine in mitochondria in different 
incubation systems 
System Incubation time (min) 
0 30 
Control (n = 7) 1.34 ? 0.28 1.57 + 0.28 
Ca’+ (n = 10) 3.00 + 0.70 
Ca’+, LPS (n = 10) 2.56 + 0.58 
Ca’+, A-23187 (n = 6) 3.23 + 0.34 
LPS (n = 6) 1.79 * 0.11 
A-23187 (n = 6) 1.36 + 0.25 
Values are referred to the total ethanolamine phosphoglycerides 
60 
1.94 k 0.36 
2.32 + 0.32 
1.88 * 0.43 
_ 
1.32 ? 0.28 
1.43 f 0.13 
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3. Results and discussion 
Rat liver mitochondria were incubated in vitro in 
the presence of endotoxin, Ca’+, ionophore A-23 187 
and their mixtures and the levels of lysophosphatidyl- 
ethanolamine were evaluated in all cases (table 1). 
The precise determination of this lyso-derivative 
was done by [I4 Clethanolamine injection into the 
rats before sacrifice; thus, the levels of phospha- 
tidylethanolamine and its lyso-form were carefully 
evaluated by radioactivity measurement after two- 
dimensional thin-layer chromatography. As can be 
seen in table 1, the presence of lipopolysaccharide 
is only accompanied by a small alteration in the 
relative content of lysophosphatidylethanolamine 
when mitochondria were incubated for as long as 
30 min, but it is accompanied by a notable increase 
in the mitochondrial content of some free fatty acids 
(table 2). However, a clear increase in the amount of 
mitochondrial lysophosphatidylethanolamine is 
achieved in response to Ca” alone or plus either 
lipopolysaccharide or the ionophore; thus, the pres- 
ence of Ca’+ results in a notable alteration of the 
phospholipid composition. The presence of the iono- 
phore A-23187 does not modify the relative composi- 
tion of mitochondrial ethanolamine phosphoglycer- 
ides. In the light of a positional analysis of phospho- 
lipid acyl moieties, these data suggest hat 1 -acyl- 
lysophosphatidylethanolamine accumulates in mito- 
chondria in response to Ca*+ loading. 
The free fatty acid accumulation correlates exten- 
sively with the increase of the lyso-derivative. Table 2 
gives the relative release of two groups of fatty acids, 
saturated and monounsaturated fatty acids acylating 
carbon 1 of the glycerol moiety, and the polyunsatu- 
rated acids occurring at carbon 2. These values dem- 
onstrate the high extent to which the positional 
segregation of individual fatty acid species affects 
position 2. Thus, the absence of release of fatty acids 
by the ionophore correlates with the constancy of 
mitochondrial lysophosphatidylethanolamine. Fur- 
ther, Ca*+ induces the accumulation in mitochondria 
Table 2 
Ratios of pg free fatty acid/pg free fatty acid in control mitochondria 
Fatty Incubation system 
acid 
Ca*+ Ca’+ + LPS A-23187 + Cal+ LPS A-23187 
16:0 1.08 * 0.12 1.03 f 0.06 1.04 f 0.12 0.98 + 0.07 1.00 t 0.20 
18:0 1.48 k 0.34 1.53 + 0.37 l.18 r 0.32 1.64 + 0.16 0.93 * 0.19 
18:l 1.85 f 0.49 1.38 f 0.23 1.18 * 0.23 0.97 f 0.02 1.15 t 0.32 
18:2 6.72 f 1.75 4.42 + 0.80 4.57 k 0.44 1.40 f 0.55 1.06 r 0.10 
20:4a 1.54 f 0.35 1.99 * 0.68 1.19 i: 0.15 2.24 * 0.20 1.20 ? 0.42 
a Including 20: 3 
Mitochondria were incubated for 30 min in different systems (n as in table 1) 
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of linoleic acid, that is partially counteracted by the 
simultaneous presence of endotoxin. However, the 
release of fatty acids from phosphatidylethanolamine 
attained under mitochondrial membrane loading con- 
ditions with lipopolysaccharide results in a selective 
increase in the level of arachidonic acid; supported by 
[lo] where a high correlation of the arachidonic acid 
content in mitochondria with the shock process was 
established. The specific release of arachidonic acid 
stimulated by lipopolysaccharide is also in agreement 
with the low increase in the levels of the lysoderivative 
produced by the endotoxin. Since both polyunsatu- 
rated fatty acids, 18:2 and 20:4, are mainly located 
at position 2 of phosphatidylethanolamine, the pref- 
erential accumulation of either linoleic acid or ara- 
chidonic acid, induced by Ca’+ or lipopolysaccharide, 
respectively, could result from a degree of enzyme 
specificity of phosphoIipase AZ towards classes of 
substrate. 
Fig.1 shows the in vitro variation of concentra- 
tions of extramitochondrial calcium in a series of 
conditions, measured through the absorbance changes 
at 540-S 10 nm in a dual wavelength spectrophotom- 
eter using murexide as indicator. The addition of 
CaC12 is followed by an initial decrease of Ca’+ and 
the corresponding translocation into the mitochondria. 
The initial slope of Cal+ translocation gives an indica- 
tion of the uptake rate of a certain amount of calcium. 
The total amount of cation translocated varies accord- 
ing to the experiment and afterwards calcium is 
released from the mitochondria into the medium. 
The presence of 1.2 mg lipopolysaccharide/ml clearly 
accelerates the uptake that achieves its maximum 
value at -4 min after the addition of the Ca*+ to the 
system; the higher the concentration of lipopolysac- 
600, 
5 10 15 20 
Time (min) 
Fig.1. Changes of extramitochondrial c cium concentration 
using 30 PM murexide as indicator. Rat liver mitochondrial 
protein concentration 2 mg/ml. Control (-); 0.2 lipo- 
polysaccharide/ml (---); 1.2 mg lipopolysaccharide/ml 
(-.-.-); 4 @M ionophore A-23187 ( . . . ). 
charide, the higher the rate of calcium uptake by the 
mitochondria. Thus, in the concentration range stud- 
ied, the presence of lipopolysaccharide correlates 
closely with the rate of Ca*+ uptake; also, the higher 
the levels of lipopolysaccharide the more rapid is Ca2+ 
release from the mitochondria. 
These data support the proposal that lipopolysac- 
charide modifies the Ca*’ uptake and the Ca*+-activa- 
tion of the mitochondrial phospholipase A2 with 
resulting hydrolysis of inner membrane phospholipids 
and increase in the permeability. 
Comparison of data from table 2 and fig.1 indicates, 
nevertheless, that the effect of lipopolysaccharide on 
the mitochondria does not follow a fatty acid pattern 
identical to that of Ca*+ added to the incubation 
medium, although the endotoxin effect involves a 
Table 3 
Mitochondrial phosphoglycerides (gg P/mg mitochondrial protein) in different shock 
conditions 
State Phosphoglyceride 
PE LPE PC LPC 
Control 1.54 f 0.45 0.062 f 0.013 (3.8)a 2.11 ?r 0.30 0.016 * 0.009 (0.7)b 
E, 1.74 * 0.34 0.061 f 0.027 (3.4) 2.18 f 0.25 0.020 + 0.012 (0.9) 
E* 1.34 ? 0.22 0.120 + 0.028 (8.2) 2.33 + 0.30 0.150 f 0.029 (6.0) 
a Percentages of the total ethanolamine phosphoglycerides 
b Percentages of the total choline phosphoglycerides 
E,, Reversible endotoxic state; E,, Irreversible endotoxic state 
117 
T
a
b
le
 4
 
Le
v
e
ls
 o
f 
fr
e
e
 f
a
tt
y 
a
ci
d
s,
in
 s
e
ru
m
 &
g
/m
l)
, 
liv
e
r 
(n
g
/m
g
 p
ro
te
in
) 
a
n
d
 l
iv
e
r 
m
it
o
ch
o
n
d
ri
a
 
(n
g
/m
g
 p
ro
te
in
) 
in
 d
if
fe
re
n
t 
sh
o
ck
 c
o
n
d
it
io
n
s 
Fa
tt
y 
S
e
ru
m
 
Li
ve
r 
M
it
o
ch
o
n
d
ri
a
 
a
ci
d
 
2
 
C
o
n
tr
o
l 
E
, 
E
, 
C
o
n
tr
o
l 
E
, 
E
* 
C
o
n
tr
o
l 
E
, 
E
, 
z?
l 
T
o
ta
l 
1
2
1
 
+
3
0
 
1
5
5
 
+
4
0
 
2
0
7
 
f 
5
0
 
2
.0
3
 f
 0
.2
2
 
2
.1
6
 f
 0
.2
4
 
2
.7
0
 +
 0
.6
2
 
1
.2
4
 +
 0
.3
8
 
1
.4
3
 +
 0
.2
6
 
4
.8
3
 f
 0
.4
9
 
K
 
1
6
:0
 
3
9
.0
 f
 
3
.5
 
5
8
.7
 t
 
6
.1
 
8
2
.8
 f
 
1
4
.4
 
1
.0
8
 +
 0
.0
2
 
1
.2
0
 f
 0
.1
9
 
1
.2
7
 *
 0
.1
2
 
0
.4
9
 *
 0
.1
6
 
0
.5
9
 r
 0
.1
9
 
1
.5
5
 t
 0
.3
0
 
2
 
1
8
:l
 
3
1
.4
 f
 
1
4
.2
 
3
8
.8
 r
 
1
1
.6
 
2
9
.4
 r
 
6
.8
 
0
.4
2
 +
 0
.1
0
 
0
.4
6
 f
 0
.1
1
 
0
.7
8
 ?
; 0
.2
0
 
0
.3
5
 *
 0
.0
9
 
0
.4
1
 *
 0
.1
0
 
0
.9
2
 r
 0
.1
7
 
B
 
~
 
1
8
:2
 
2
1
.2
 f
 
1
0
.9
 
1
3
.6
 +
 
6
.6
 
2
.0
 +
 
0
.4
 
0
.1
6
 f
 
0
.0
5
 
0
.1
1
 +
 0
.0
5
 
0
.3
9
 f
 
0
.1
4
 
0
.0
4
 ?
 0
.0
2
 
0
.0
4
 r
 0
.0
1
 
0
.2
2
 *
 0
.0
7
 
2
0
:4
 
1
.4
 f
 
0
.5
 
1
.1
 +
 
0
.3
 
1
.7
 f
 
0
.1
 
0
.0
2
 i
 
0
.0
1
 
0
.0
3
 *
 0
.0
1
 
0
.0
3
 *
 0
.0
1
 
0
.0
1
 A
 0
.0
0
5
 
0
.0
2
 +
 0
.0
1
 
0
.2
0
 i
 
0
.0
2
 
E
,,
 
R
e
v
e
rs
ib
le
 e
n
d
o
to
xi
c 
st
a
te
; E
,,
 
Ir
re
v
e
rs
ib
le
 e
n
d
o
to
xi
c 
st
a
te
 
Volume 127. number 1 FEBS LETTERS May 1981 
significant uptake and mobilization of the cation. The 
difference is mainly concerned with the nature of 
fatty acid release from the phospholipids, either 18:2 
or 20:4, according to the mitochondrial treatment. In 
both cases, either lipopolysaccharide or Ca’+ treat- 
ment, the large scale hydrolysis of endogenous phos- 
pholipids is likely due to the involvement of a mito- 
chondrial phospholipase; on the other hand, the 
preferential release of polyunsaturated fatty acids 
could be interpreted to indicate that different phos- 
pholipids are selectively distributed in the mitochon- 
drial membranes. It is clear, then, that lipopolysac- 
charide stimulates Ca’+ uptake by the mitochondria, 
possibly through stimulation of Ca2+ binding. The 
endotoxin-mediated stimulation of Ca2+uptake shows 
concentration dependency and provokes simulta- 
neously a decrease in the variation ratio 18:2/20:4 of 
the released fatty acids, that becomes <l when lipo- 
polysaccharide acts in the absence of Ca2+ (table 2). 
Phospholipids from the outer membrane, mainly 
phosphatidylethanolamine and phosphatidylcholine, 
contain high percentages of 20:4 while 18:2 is spe- 
cially abundant in phospholipids, including cardio- 
lipins, from the inner mitochondrial membrane. It is 
also known that calcium influences the structure of 
membranes containing acidic phospholipids [24-321 
through fusion [24,25], lateral phase separation 
[26-291 and permeability changes; the release of 
bound calcium accompanies a phospholipid structural 
reorganization [30] mainly dependent upon calcium 
concentration, ionic strength and phospholipid molec- 
ular species [29-32,331. In spite of these observa- 
tions it is not possible to predict the structural or 
organizational impact of calcium on any native bio- 
logical membrane [34]. These data could support 
the proposal that intramitochondrial phospholipase 
A2 is activated by either Cal+ or lipopolysaccharide 
at locations with different phospholipid environments 
from which the different polyunsaturated fatty acids 
are released. Also, the Ca2+-dependent mobilization 
of arachidonic acid from an endogenous phospholipid 
pool lends support to the idea that Ca’+-mediated 
activation of phospholipase A2 participates in the 
control of mitochondrial activity. 
Ionophore A-23 187 alone does not result in any 
significant influence on the level of lyso-derivative 
(table 1) nor in the modification of the fatty acid 
release (table 2); also, the presence of the ionophore 
in the Ca’+-system does not affect the variations 
mediated through Ca2+ alone. 
Table 3 gives the induced changes in the levels of 
phosphatidylethanolamine, phosphatidylcholine and 
their lyso-derivatives by endotoxin given in vivo at 
two different clinical states of shock. Thus, a reversible 
endotoxic state does not induce any modification on 
these levels whereas in an irreversible state the levels 
of both lyso-derivatives increase markedly. However, 
the constancy in the levels of the diacylated phospho- 
glycerides may be explained through transacylation 
reactions in agreement with other results [35] on 
the increase of palmitoyl transferase in dog heart 
mitochondria by endotoxin given in vivo or in vitro. 
The net results of this situation would be an activa- 
tion of the lipolytic system with a generalized increase 
of mitochondrial free fatty acids that influence, 
although to a lesser extent, the fatty acid content of 
liver and serum (table 4) at the irreversible shock 
state. Concerning the nature of the fatty acids released 
in vivo, the relative increase follows the order 20:4 > 
18:2 > 18:l = 16:0 in both liver mitochondria and 
liver; this variation does not affect significantly the 
levels of free fatty acids in the serum. Interestingly, 
the level of 18:2 in the serum free fatty acids at the 
irreversible shock condition is extremely low, suggest- 
ing an in vivo specific activity of lipopolysaccharide 
on either lipolytic activity of adipose tissue or fatty 
acid reutilization; it is difficult, however, to evaluate 
the physiopathological relevance of this result at this 
time. 
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